Webinar: Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing

© poba/Getty Images
© poba/Getty Images

Life Sciences industry is undergoing a fundamental shift, driven by new technologies, e.g. personalized medicines, digital health, continuous processes, as well as the drive to lower healthcare cost and changes in re-imbursement to a value-based pricing model.

Digitalization is instrumental in facilitating a successful transformation to a flexible, agile and cost-effective pharma manufacturing. Virtual twins can significantly improve the quality and efficiency of projects in engineering and commissioning as well as help improve performance during operations and maintenance.

 

Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing
March 26, 2020 | 10.00 a.m. (CET)

           

Join this webinar to:

  • Understand the current industry challenges and the limitations of current approaches
  • Discover how using a virtual twin approach can bring value
  • Learn from practical experiences

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.